Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$0.66 - $1.29 $24,343 - $47,580
36,884 New
36,884 $27,000
Q3 2021

Nov 10, 2021

SELL
$5.54 - $7.51 $296,783 - $402,318
-53,571 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$7.78 - $11.4 $387,654 - $568,027
-49,827 Reduced 48.19%
53,571 $455,000
Q4 2020

Feb 12, 2021

SELL
$3.16 - $7.03 $138,600 - $308,342
-43,861 Reduced 29.78%
103,398 $602,000
Q3 2020

Nov 12, 2020

BUY
$3.26 - $4.73 $85,128 - $123,514
26,113 Added 21.55%
147,259 $499,000
Q3 2019

Nov 14, 2019

BUY
$2.67 - $3.65 $148,072 - $202,421
55,458 Added 84.43%
121,146 $356,000
Q2 2019

Aug 13, 2019

BUY
$2.6 - $4.21 $170,788 - $276,546
65,688 New
65,688 $189,000

Others Institutions Holding AFMD

About Affimed N.V.


  • Ticker AFMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,339,008
  • Market Cap $185M
  • Description
  • Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...
More about AFMD
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.